medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2006, Número 03

<< Anterior Siguiente >>

Ginecol Obstet Mex 2006; 74 (03)


Cardiopatía y embarazo

Cano LH, Cano AHE, Cano AFD

Idioma: Español
Referencias bibliográficas: 28
Paginas: 153-157
Archivo PDF: 288.47 Kb.


RESUMEN

Se presenta un estudio de recapitulación de una de las causas indirectas más frecuentes de mortalidad materna. El objetivo principal es crear conciencia y alertar a la población médica de la necesidad del diagnóstico oportuno y el tratamiento adecuado cardiológico y obstétrico. Se hace referencia a los principales cambios hemodinámicos en la mujer embarazada, el riesgo de muerte según el padecimiento específico y a los parámetros de control obstétricos y cardiológicos. Con esto se trata de disminuir lo más posible la mortalidad materna y perinatal.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: Findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159(2):379-83.

  2. Shiferaw T, Tesseman F. Maternal mortality rural communities of Illubabor southwestern Ethiopia: As estimated by the “sisterhood method”. Ethiop Med J 1999;31:239-49.

  3. Centers for Disease Control and Prevention (CDC). Maternal mortality, United States, 1982-1996. MMWR Morb Mortal Wkyl Rep 1998;47:705-7.

  4. Hernández B, Chirinos J, Romero M, Langer A. Estimating maternal mortality in rural areas of Mexico: The application of an indirect demographic method. Int J Gynecol Obstet 1994;46:285-9.

  5. MacKay AO, Berg CJ, Atrash HK. Pregnancy-related mortality from preclampsia and eclampsia. Obstet Gynecol 2001;97:533-8.

  6. Maine D, Freedman L, Shaheed F, et al. Risk and right: The use of reproductive health data. Reprod Health Matters 1995;6:40-51.

  7. Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500-9.

  8. Okanloma KA, Moodley J. Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet 2000;71:223-5.

  9. Jowett M. Safe motherhood interventions in low income countries: An economic justification and evidence of cost effectiveness. Health Policy 2000;53:201-28.

  10. Kochanek KD, Hudson BL. Advance Report of Final Mortality Statistics 1992. Monthly Vital Statistics Report, Vol. 43, No. 6, Suppl. Hyattsille, MD, National Center for Health Statistics, 1994.

  11. Le Bacq F, Rietsema A. High maternal mortality levels and additional risk from poor accessibility in two districts of Northern Province, Zambia. Int J Epidemiol 1997;26:357-63.

  12. Olsen BE, Hinderaker SG, Kazaura M, et al. Estimates of maternal mortality by the sisterhood method in rural northern Tanzania: A household sample and an antenatal clinic sample. Br J Obstet Gynaecol 2000;107:124-35.

  13. Boerma JT. Levels of maternal mortality in developing countries. Stud Fam Plann 1987;18:213-21.

  14. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. Engl J Med 1996;335:108-14.

  15. Wirawn DN, Linnan M. The bail indirect maternal mortality study. Stud Fam Plann 1991;25:304-9.

  16. American College of Obstetricians and Gynecologist. FIGO “Save the Mothers” project on curse. ACOG Today 2000;10:8.

  17. Atrash HK, Alexander S, Berg CJ. Maternal mortality in developed countries. Not just a concern of the past. Bostet Gynecol 1995;86:700-5.

  18. Sule-Odu AO. Maternal deaths in Sagamu, Nigeria. Int J Gynecol Obstet 2000;69:47-9.

  19. Thompson A. Poor pregnant in Africa: Safe motherhood and human rights. Midwifery 1999;15:146-53.

  20. International Federation of Gynaecology and Obstetrics (FIGO). FIGO save the mothers fund. FIGO Newsletter 2001:1.

  21. Zunker P, Happe S, Georgiadis AL, et al. Maternal cerebral hemodynamics inpregnancy–related hypertension: A prospective transcranial Doppler study. Ultrasound Obstet Gynecol 2000;16:179-87.

  22. Jeejeeboy S. Empower women, ensure choice. In: Starr A. The Safe Motherhood Action Agenda: Priorities for the next decade. Report of the Safe Motherhood Technical Consultation, Columbo, New York, Family Care International, 1998.

  23. World Health Organization, ICD-10: International Statistical Classification of Diseases and Health Related Problems”. Vol 1, 10 ed., Geneva, WHO, 1992.

  24. Lindenstrom E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk; a prospective observational study. Am J Epidemiol 1995;142:1279-90.

  25. Artal R, Fortunato V, Welton A, et al. A comparison of cardiopulmonary adaptations to exercise inpregnancy at sea level and altitude. Am J Obstet Gynecol 1995;172:1170-80.

  26. Rasmussen C, Wadt B, Jacobsen B. Thromboembolic prophylaxis with low molecular weight heparin during pregnancy. Int J Gynaecol Obstet 1994;47:121-5.

  27. Subril D, Goeusse P, Puech F, et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women. The Essai Regional Aspirine Mere-Enfant study (Part I) 2003;110(5):475-84.

  28. Berhance Y, Andersson T, Wall S, Byass P, Hogberg U. Aims options and outcomes in measuring maternal mortality in developing societies. Acta Obstet Gynecol Scand 2000,79:968-72.




2020     |     www.medigraphic.com